Erector Spinae Versus Paravertebral in Pediatric PCNL
Ultrasound-guided Erector Spinae Plane Block Versus Ultrasound-guided Thoracic Paravertebral Block in Pediatric Patients Undergoing Percutaneous Nephrolithotomy
1 other identifier
interventional
56
1 country
1
Brief Summary
To compare the efficacy of ultrasound-guided erector spinae plane block versus ultrasound-guided paravertebral block in pediatric patients undergoing percutaneous nephrolithotomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2022
CompletedFirst Posted
Study publicly available on registry
October 21, 2022
CompletedStudy Start
First participant enrolled
October 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2023
CompletedJanuary 10, 2024
January 1, 2024
11 months
October 18, 2022
January 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Total consumption of nalbuphine
The first 24 hours postoperatively
Time to first rescue analgesia
The first 24 hours postoperatively
Secondary Outcomes (2)
The concentration of sevoflurane in percent
Through the surgery, an average of 2 hours
Systolic, diastolic, and mean blood pressure during surgery in mmHg
Through the surgery, an average of 2 hours
Study Arms (2)
Erector spinae plane block
EXPERIMENTALUltrasound-guided erector spinae plane block
Paravertebral
EXPERIMENTALUltrasound-guided thoracic paravertebral block
Interventions
Ultrasound-guided erector spinae plane block
Eligibility Criteria
You may qualify if:
- Patients undergoing percutaneous nephrolithotomy
You may not qualify if:
- Coagulation disorders
- Infection at the site of injection
- Allergy to the local anesthetics used
- Spinal cord abnormalities or neurological deficits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 71515, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 18, 2022
First Posted
October 21, 2022
Study Start
October 26, 2022
Primary Completion
September 27, 2023
Study Completion
December 27, 2023
Last Updated
January 10, 2024
Record last verified: 2024-01